Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study

References

• van den Beuken-van EverdingenMHde RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol20071891437144917355955
   PubMed Web of Science ®Google Scholar
• KroenkeKTheobaldDWuJLozaJKCarpenterJSTuWThe association of depression and pain with health-related quality of life, disability, and health care use in cancer patientsJ Pain Symptom Manage201040332734120580201
   PubMed Web of Science ®Google Scholar
• World Health OrganizationCancer Pain Relief: With a Guide to Opioid Availability2nd edGeneva, SwitzerlandWorld Health Organization1996
   Google Scholar
• MeuserTPietruckCRadbruchLStutePLehmannKAGrondSSymptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiologyPain200193324725711514084
   PubMed Web of Science ®Google Scholar
• BellTJPanchalSJMiaskowskiCBolgeSCMilanovaTWilliamsonRThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)Pain Med2009101354218721170
   PubMed Web of Science ®Google Scholar
• PappagalloMIncidence, prevalence, and management of opioid bowel dysfunctionAm J Surg2001182Suppl 5A11S18S11755892
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFJvan den HaakPKlokRMPrevooYFvan der PeetDLHeringsRMQuality of life in relation to constipation among opioid usersJ Med Econ201013112913520128662
   PubMedGoogle Scholar
• ManaraLBianchiGFerrettiPTavaniAInhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sitesJ Pharmacol Exp Ther198623739459493012075
   PubMed Web of Science ®Google Scholar
• FishmanJRoffwargHHellmanLDisposition of naloxone-7,8,3H in normal and narcotic-dependent menJ Pharmacol Exp Ther197318735755804588968
   PubMed Web of Science ®Google Scholar
• LiuMWittbrodtELow-dose oral naloxone reverses opioid-induced constipation and analgesiaJ Pain Symptom Manage2002231485311779668
   PubMed Web of Science ®Google Scholar
• MeissnerWSchmidtUHartmannMKathRReinhartKOral naloxone reverses opioid-associated constipationPain200084110510910601678
   PubMed Web of Science ®Google Scholar
• SykesNPAn investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancerPalliat Med19961021351448800821
   PubMed Web of Science ®Google Scholar
• ReimerKHoppMZenzMMeeting the challenges of opioid-induced constipation in chronic pain management – a novel approachPharmacology2009831101718957874
   PubMed Web of Science ®Google Scholar
• VondrackovaDLeyendeckerPMeissnerWAnalgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic painJ Pain20089121144115418708300
   PubMed Web of Science ®Google Scholar
• SimpsonKLeyendeckerPHoppMFixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer painCurr Med Res Opin200824123503351219032132
   PubMed Web of Science ®Google Scholar
• LöwensteinOLeyendeckerPHoppMCombined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trialExp Opin Pharmacother2009104531543
   PubMed Web of Science ®Google Scholar
• LöwensteinOLeyendeckerPLuxEAEfficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsBMC Clin Pharmacol2010101220920236
   PubMedGoogle Scholar
• SchutterUGrunertSMeyerCSchmidtTNolteTInnovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practiceCurr Med Res Opin20102661377138720380506
   PubMed Web of Science ®Google Scholar
• CleelandCSRyanKMPain assessment: global use of the Brief Pain InventoryAnn Acad Med Singapore19942321291388080219
   PubMedGoogle Scholar
• RadbruchLLoickGKienckePValidation of the German version of the Brief Pain InventoryJ Pain Symptom Manage199918318018710517039
   PubMed Web of Science ®Google Scholar
• RentzAMYuRMüller-LissnerSLeyendeckerPValidation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipationJ Med Econ200912437138319912069
   PubMedGoogle Scholar
• RentzAMvan Hanswijck de JongePLeyendeckerPHoppMObservational, nonintervention, multicenter study for validation of the Bowel Function Index for constipation in European countriesCurr Med Res Opin2011271354421083515
   PubMed Web of Science ®Google Scholar
• UeberallMAMüller-LissnerSBuschmann-KrammCBosseBThe Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patientsJ Int Med Res2011391415021672306
   PubMed Web of Science ®Google Scholar
• McNicolEDBoyceDSchumannRCarrDBMu-opioid antagonists for opioid-induced bowel dysfunctionCochrane Database Syst Rev20082CD00633218425947
   PubMed Web of Science ®Google Scholar
• ThomasJKarverSCooneyGAMethylnaltrexone for opioid-induced constipation in advanced illnessN Engl J Med2008358222332234318509120
   PubMed Web of Science ®Google Scholar
• MercadanteSEmerging drugs for cancer-related painSupport Care Cancer201119121887189321938596
   PubMed Web of Science ®Google Scholar
• McNicolEHorowicz-MehlerNFiskRAAmerical Pain SocietyManagement of opioid side effects in cancer-related and chronic noncancer pain: a systematic reviewJ Pain20034523125614622694
   PubMed Web of Science ®Google Scholar
• AhmedzaiSHNauckFBar-SelaGBosseBLeyendeckerPHoppMA randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer painPalliat Med2012261506021937568
   PubMed Web of Science ®Google Scholar
• DworkinRHTurkDCWyrwichKWInterpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendationsJ Pain20089210512118055266
   PubMed Web of Science ®Google Scholar
• HermannsKJunkerUNolteTProlonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational studyExpert Opin Pharmacother201213329931122224497
   PubMed Web of Science ®Google Scholar
• PorrecaFOssipovMHNausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management optionsPain Med200910465466219302436
   PubMed Web of Science ®Google Scholar
• FossJFYuanCSRoizenMFGoldbergLIPrevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphineCancer Chemother Pharmacol19984242872919744773
   PubMed Web of Science ®Google Scholar
• MurphyDBSuttonJAPrescottLFMurphyMBOpioid-induced delay in gastric emptying: a peripheral mechanism in humansAnesthesiology19978747657709357876
   PubMed Web of Science ®Google Scholar
• CaraceniAChernyNFainsingerRPain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative CareJ Pain Symptom Manage200223323925511888722
   PubMed Web of Science ®Google Scholar
• FerrellBRThe impact of pain on quality of life. A decade of researchNurs Clin North Am19953046096247501531
   PubMed Web of Science ®Google Scholar
• ReidCMMartinRMSterneJADaviesANHanksGWOxycodone for cancer-related pain: meta-analysis of randomized controlled trialsArch Intern Med2006166883784316636208
   PubMedGoogle Scholar